BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 20647322)

  • 41. [Prediction of T-cell immune reconstitution by investigating T cell receptor excision circle and T-cell receptor beta-chain variable region clonal repertoire in leukemia patients after allogeneic hematopoietic stem cell transplantation].
    Fu YW; Wu DP; Cen JN; Feng YF; Chang WR; Qiu QC; Zhu ZL; Zhu P
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2265-7. PubMed ID: 18001548
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Limited T cell receptor usage by HTLV-I tax-specific, HLA class I restricted cytotoxic T lymphocytes from patients with HTLV-I associated neurological disease.
    Elovaara I; Utz U; Smith S; Jacobson S
    J Neuroimmunol; 1995 Dec; 63(1):47-53. PubMed ID: 8557824
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers.
    Takamori A; Hasegawa A; Utsunomiya A; Maeda Y; Yamano Y; Masuda M; Shimizu Y; Tamai Y; Sasada A; Zeng N; Choi I; Uike N; Okamura J; Watanabe T; Masuda T; Kannagi M
    Retrovirology; 2011 Dec; 8():100. PubMed ID: 22151736
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals.
    Eiraku N; Hingorani R; Ijichi S; Machigashira K; Gregersen PK; Monteiro J; Usuku K; Yashiki S; Sonoda S; Osame M; Hall WW
    J Immunol; 1998 Dec; 161(12):6674-80. PubMed ID: 9862696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation.
    Narita T; Ishida T; Masaki A; Suzuki S; Ito A; Mori F; Yamada T; Ri M; Kusumoto S; Komatsu H; Miyazaki Y; Takatsuka Y; Utsunomiya A; Niimi A; Iida S; Ueda R
    J Immunol; 2014 Feb; 192(3):940-7. PubMed ID: 24363428
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
    Nolte A; Buhmann R; Straka C; Emmerich B; Hallek M
    Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.
    Jacobson S; Reuben JS; Streilein RD; Palker TJ
    J Immunol; 1991 Feb; 146(4):1155-62. PubMed ID: 1704032
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunogenicity of human T cell leukemia virus type-I (HTLV-I) antigens for cytotoxic T lymphocytes in the rat system.
    Tanaka Y; Isobe A; Masuda M; Tozawa H; Koyanagi Y; Yamamoto N; Shida H
    J Immunol; 1991 Nov; 147(10):3646-52. PubMed ID: 1940363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of AID by human T-cell leukemia virus Tax oncoprotein and the possible role of its constitutive expression in ATL genesis.
    Ishikawa C; Nakachi S; Senba M; Sugai M; Mori N
    Carcinogenesis; 2011 Jan; 32(1):110-9. PubMed ID: 20974684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NF-kappaB in pathogenesis and treatment of adult T-cell leukemia/lymphoma.
    Horie R
    Int Rev Immunol; 2007; 26(5-6):269-81. PubMed ID: 18027201
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
    Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
    Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine.
    Ohashi T; Hanabuchi S; Kato H; Tateno H; Takemura F; Tsukahara T; Koya Y; Hasegawa A; Masuda T; Kannagi M
    J Virol; 2000 Oct; 74(20):9610-6. PubMed ID: 11000233
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro peptide immunization of target tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytes.
    Kobayashi H; Ngato T; Sato K; Aoki N; Kimura S; Tanaka Y; Aizawa H; Tateno M; Celis E
    Clin Cancer Res; 2006 Jun; 12(12):3814-22. PubMed ID: 16778109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Graft-versus-leukemia effects of Wilms' tumor 1 protein-specific cytotoxic T lymphocytes in patients with chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
    Wang ZD; Li D; Huang XJ
    Chin Med J (Engl); 2010 Apr; 123(7):912-6. PubMed ID: 20497687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Anti-tumor immunity in adult T-cell leukemia].
    Kannagi M
    Uirusu; 2004 Jun; 54(1):67-74. PubMed ID: 15449906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential immunogenicity of adult T cell leukemia cells in vivo.
    Kurihara K; Harashima N; Hanabuchi S; Masuda M; Utsunomiya A; Tanosaki R; Tomonaga M; Ohashi T; Hasegawa A; Masuda T; Okamura J; Tanaka Y; Kannagi M
    Int J Cancer; 2005 Mar; 114(2):257-67. PubMed ID: 15551352
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
    Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
    J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired Tax-specific T-cell responses with insufficient control of HTLV-1 in a subgroup of individuals at asymptomatic and smoldering stages.
    Shimizu Y; Takamori A; Utsunomiya A; Kurimura M; Yamano Y; Hishizawa M; Hasegawa A; Kondo F; Kurihara K; Harashima N; Watanabe T; Okamura J; Masuda T; Kannagi M
    Cancer Sci; 2009 Mar; 100(3):481-9. PubMed ID: 19154412
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor.
    Sugata K; Yasunaga J; Mitobe Y; Miura M; Miyazato P; Kohara M; Matsuoka M
    Blood; 2015 Aug; 126(9):1095-105. PubMed ID: 26063164
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion.
    Utz U; Banks D; Jacobson S; Biddison WE
    J Virol; 1996 Feb; 70(2):843-51. PubMed ID: 8551623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.